Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2000
11/01/2000CN1272136A Stimulation of hematopoietic cells in vitro
11/01/2000CN1272062A Immunogenic conjugates comprising group meningococcal porin and an i (H. influenzae) polysaccharide
11/01/2000CN1271621A Process for synthesizing protein immunoadsorbent medium for removing pathogenic antibody and its compounds from plasm
10/2000
10/31/2000US6140305 Hereditary hemochromatosis gene products
10/31/2000US6140116 Adjusted swine neuronal cells for the treatment of humans with stroke, brain trauma, amyotrophic lateral sclerosis, multiple sclerosis, huntington's and alzheimer's disease
10/31/2000US6140114 Defective viral vaccine particles obtained in vivo or ex vivo
10/31/2000US6140113 Nucleotide sequences which codes an immunoglobulin fusion protein; for the detection and treatment of allergies, autoimmune diseases, tumors, infections, and transplant ejection; antitumor agents
10/31/2000US6140098 Nucleic acids encoding mammalian proteinases; related reagents
10/31/2000US6140083 Leptospiral outer membrane protein, LipL46
10/31/2000US6140079 Nucleotide sequence coding staphylococcal protein; for the prevention of bacterial infection and development of bactericides
10/31/2000US6140061 Response regulator
10/31/2000US6140059 Methods for the obtention of human immunodeficiency virsus Type 1 envelope glycoproteins in native and oligomeric form employing recombinant chimeric antigens containing collagenase recognition sites.
10/31/2000US6140058 Activation of p53 protein
10/31/2000US6140043 Pharmaceutical composition comprising a protein, peptide or a functionally equivalent molecule
10/31/2000US6139862 Pharmaceutical dipeptide compositions and methods of use thereof
10/31/2000US6139846 Protein D- an IGD-binding protein of haemophilus influenzae
10/31/2000US6139843 Administering a polypeptide conjugate compositions to enhance immunogenicity, for treatment and prevention of viral infections
10/31/2000US6139841 Activating immune response in an individual for treatment or prevention of cancer
10/31/2000CA2197684C Human-murine chimeric antibodies against respiratory syncytial virus
10/31/2000CA2185112C Humanized monoclonal antibodies against human interleukin-4
10/31/2000CA2132328C Vaccine containing live virus for therapy of viral diseases and malignancies
10/31/2000CA2009403C A packaging defective hiv provirus, cell lines, and uses thereof
10/26/2000WO2000063693A1 Improved method of identifying and locating immunobiologically-active linear peptides
10/26/2000WO2000063438A2 Method of classifying a thyroid carcinoma using differential gene expression
10/26/2000WO2000063434A1 MinK-RELATED GENES, FORMATION OF POTASSIUM CHANNELS AND ASSOCIATION WITH CARDIAC ARRHYTHMIA
10/26/2000WO2000063403A2 Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein
10/26/2000WO2000063394A2 A polypeptide having amidolytic activity for a serpin
10/26/2000WO2000063393A1 Dsp-8 dual-specificity map kinase phosphatase
10/26/2000WO2000063386A2 Prevention, diagnosis and treatment of lyme disease
10/26/2000WO2000063385A2 Nucleic acid immunization
10/26/2000WO2000063381A1 Mammalian protein with putative function in signal transduction
10/26/2000WO2000063378A2 Zalpha13: a human secreted protein
10/26/2000WO2000063376A1 Adipocyte complement related protein homolog zacrp2
10/26/2000WO2000063370A2 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes
10/26/2000WO2000063363A1 Peptide from antigen muc-1 for triggering an immune response to tumor cells
10/26/2000WO2000063352A2 Human homologues of fused gene
10/26/2000WO2000063350A2 Cysteine protease and inhibitors for prevention and treatment of neurocysticerocosis
10/26/2000WO2000063252A1 Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline to its high affinity receptor
10/26/2000WO2000063251A1 Composition and method for modulating dendritic cell-t cell interaction
10/26/2000WO2000063245A2 Variant of the plasmodium merozoite surface protein (msp-1) and vaccine comprising said variant
10/26/2000WO2000063244A1 Parasite antigens
10/26/2000WO2000063230A2 49 human secreted proteins
10/26/2000WO2000062818A1 Differentiation of monocytes into functional dendritic cells
10/26/2000WO2000062817A2 Inducible vaccines
10/26/2000WO2000062816A2 Genetic tolerization
10/26/2000WO2000062815A2 Novel pharmaceutical composition suitable for gene therapy
10/26/2000WO2000062813A2 Cationic peg-lipids and methods of use
10/26/2000WO2000062807A1 Diagnosis and treatment of neuroectodermal tumors
10/26/2000WO2000062806A1 Treatment of adult rheumatoid arthritis by oral administration of pooled human immunoglobulin and an antacid
10/26/2000WO2000062804A2 Identification of sortase gene
10/26/2000WO2000062803A2 ppGpp AND pppGpp AS IMMUNOMODULATORY AGENTS
10/26/2000WO2000062802A2 Vaccine comprising rsv antigen and cpg oligonucleotide
10/26/2000WO2000062801A2 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv)
10/26/2000WO2000062800A2 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
10/26/2000WO2000062791A1 D-form polypeptide which induces immune tolerance and methods of use
10/26/2000WO2000062787A1 Methods and compositions for use in potentiating antigen presentation by antigen presenting cells
10/26/2000WO2000062758A1 A method for improving the half-life of soluble viral-specific ligands on mucosal membranes
10/26/2000WO2000062657A2 Improvement of t cell mediated immunity
10/26/2000WO2000037646A3 Group b streptococcus proteins, and their use
10/26/2000WO2000036089A3 Methods of immunosuppression
10/26/2000WO2000035482A3 Novel adjuvant for subunit or component vaccines
10/26/2000WO2000035481A3 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation
10/26/2000WO2000035477A3 Multi-component vaccine comprising at least two antigens from haemophilus influenzae
10/26/2000WO2000034465A3 HEAT SHOCK GENES AND PROTEINS FROM NEISSERIA MENINGITIDIS, CANDIDA GLABRATA AND $i(ASPERGILLUS FUMIGATUS)
10/26/2000WO2000034444A3 Method and composition for preserving viruses
10/26/2000WO2000034294A3 Tumor necrosis factor receptor homologue-1 ('trh1')
10/26/2000WO2000025808A8 Inhibition of differentiation of cytotoxic t-cells by p-selectin ligand (psgl) antagonists
10/26/2000WO2000018906A3 Shuffling of codon altered genes
10/26/2000WO2000018795A3 Compositions and methods for wt1 specific immunotherapy
10/26/2000WO2000016801A9 Methods of downmodulating the immune response to therapeutic proteins
10/26/2000WO2000011172A9 Antithrombin nucleotides and proteins from horn fly
10/26/2000WO2000006206A9 Compositions and methods for the treatment and diagnosis of cardiovascular disease
10/26/2000DE19918682A1 New recombinant DNA encoding an allergen produced by grasses of the Poaceae family, useful for diagnosis of pollen allergy and for treatment by desensitization
10/26/2000DE19918327A1 Generating donor tolerance in humans, useful for inducing compatibility with xenotransplants, comprises injection of fetus or embryo with donor stem cells
10/26/2000CA2373359A1 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes
10/26/2000CA2370945A1 Method of classifying a thyroid carcinoma using differential gene expression
10/26/2000CA2370760A1 Improved method of identifying and locating immunobiologically-active linear peptides
10/26/2000CA2370708A1 Vaccine comprising rsv antigen and cpg oligonucleotide
10/26/2000CA2370690A1 Cationic peg-lipids and methods of use
10/26/2000CA2370646A1 Nucleic acid immunization
10/26/2000CA2370617A1 Dsp-8 dual-specificity map kinase phosphatase
10/26/2000CA2370602A1 Adipocyte complement related protein homolog zacrp2
10/26/2000CA2370296A1 Improvement of t cell mediated immunity
10/26/2000CA2370268A1 Treatment of adult rheumatoid arthritis by oral administration of pooled human immunoglobulin and an antacid
10/26/2000CA2369762A1 A method for improving the half-life of soluble viral-specific ligands on mucosal membranes
10/26/2000CA2368839A1 D-form polypeptide which induces immune tolerance and methods of use
10/26/2000CA2365579A1 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv)
10/26/2000CA2365523A1 Identification of sortase gene
10/26/2000CA2365424A1 Prevention, diagnosis and treatment of lyme disease
10/26/2000CA2364209A1 49 human secreted proteins
10/26/2000CA2364191A1 Parasite antigens
10/26/2000CA2330231A1 Composition and method for modulating dendritic cell-t cell interaction
10/25/2000EP1046652A1 Method for quantitating denatured ldls
10/25/2000EP1046651A1 Composition and method for modulating dendritic cell-T interaction
10/25/2000EP1045910A1 Trypanosoma cruzi antigen, gene encoding therefor, and methods of detecting and treating chagas disease
10/25/2000EP1045859A1 NOVEL SURFACE PROTEIN OF $i(NEISSERIA MENINGITIDIS)
10/25/2000EP1045701A1 Methods of using human receptor protein 4-1bb
10/25/2000EP1045700A1 Oral delivery of nucleic acid vaccines by particulate complexes
10/25/2000EP1045699A1 Genetic immunization with co-delivery of nucleic acid and cytokines in a single vehicle
10/25/2000EP1045698A1 Patient-specific white blood cell malignancy vaccine from membrane-proteoliposomes
1 ... 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 1469 1470 1471 ... 1823